高级搜索
恶性肿瘤临终患者血浆D-二聚体动态检测回顾性分析[J]. 肿瘤防治研究, 2014, 41(04): 350-352. DOI: 10.3971/j.issn.1000-8578.2014.04.014
引用本文: 恶性肿瘤临终患者血浆D-二聚体动态检测回顾性分析[J]. 肿瘤防治研究, 2014, 41(04): 350-352. DOI: 10.3971/j.issn.1000-8578.2014.04.014
A Retrospective Analysis of Continuous Detection of Serum D-dimer in Malignancy Dying Patients[J]. Cancer Research on Prevention and Treatment, 2014, 41(04): 350-352. DOI: 10.3971/j.issn.1000-8578.2014.04.014
Citation: A Retrospective Analysis of Continuous Detection of Serum D-dimer in Malignancy Dying Patients[J]. Cancer Research on Prevention and Treatment, 2014, 41(04): 350-352. DOI: 10.3971/j.issn.1000-8578.2014.04.014

恶性肿瘤临终患者血浆D-二聚体动态检测回顾性分析

A Retrospective Analysis of Continuous Detection of Serum D-dimer in Malignancy Dying Patients

  • 摘要: 目的 分析恶性肿瘤临终患者死亡前血浆D-二聚体含量的变化与预后的关系。方法 检测72例恶性肿瘤临终患者死亡前0~4周内和4~8周内自身血浆D-二聚体值,两次检测间隔时间平均为24天,并对两次检测值进行统计分析。结果 恶性肿瘤临终患者死亡前0~4周D-血浆二聚体检测水平显著高于4~8周检测水值,差异有统计学意义(P=0.002);其中消化道恶性肿瘤差异最为明显(P=0.004),其次为肺癌(P=0.028)。然而男性和女性之间,不同年龄组间的D-二聚体变化值无明显差异(P>0.05)。结论 血浆D-二聚体变化情况可以作为恶性肿瘤临终患者预后判断的参考指标。

     

    Abstract: Objective To analyze the relationship between change in plasma D-dimer levels and prognosis of dying patients with malignant tumors. Methods The plasma D-dimer levels of 72 malignant tumor patients were measured within 0-4 weeks and 4-8 weeks before their death. The average period between these two tests was approximately 24 days apart,and the results were statistically analyzed. Results In general, the plasma D-dimer level measured in 0-4 weeks was signifi cantly higher than that in 4-8 weeks(P=0.002), with gastrointestinal malignancies having the most signifi cant difference(P=0.004), followed by lung cancer(P=0.028). However, the difference of the D-dimer levels were similar between men and women and among different age groups (P>0.05). Conclusion The plasma D-dimer levels measured at different times could be used to predict the prognosis of dying patients with malignant tumors.

     

/

返回文章
返回